POU5F1 and hepatocellular carcinoma: Nevertheless, OCT-4 appears to be of particular interest, since its expression and activity are elevated in SKOV3-R cells, raising the possibility that it plays a role in conferring CPT resistance, as reported for drug-treated hepatoma cells [80].